DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer

DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer

Palliative radiotherapy for head and neck cancer is widely used but the effect and side effects are largely unknown. We will study the effect of short hypofractionated palliative radiotherapy (20 Gy in 4 fractions) on symptom intensity and -frequency as weel as side effects

Inclusion Criteria:

• Incurable primary or second primary head and neck cancer
• Speaks and reads Danish
• Capable of filling out questionnaires for at leas two months after radiotherapy
• Age>=18 years
• Expected survival> 3months